Human Molecular Genetics Advance Access originally published online on July 16, 2008
Human Molecular Genetics 2008 17(20):3118-3127; doi:10.1093/hmg/ddn209
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The identification and characterization of a FOXL2 response element provides insights into the pathogenesis of mutant alleles
1 INSERM U567, Team 21, Département de Génétique et Développement, Institut Cochin 75014, Paris, France 2 CNRS UMR8104, Institut Cochin, 75014 Paris, France 3 Université Paris Descartes, Faculté de Médecine Cochin-Port-Royal, Paris 75014, France 4 Université Denis Diderot, Paris VII, 75013 Paris, France 5 École Normale Supérieure, 75005 Paris, France 6 Université Paris-Sud, Paris XI, 91400 Orsay, France 7 TCI Microsoft Research, Dipartimento di Fisica, Politecnico de Torino, 10129 Torino, Italia
* To whom correspondence should be addressed at: INSERM E21-GDPM, Institut Cochin, 24, Rue du Faubourg Saint-Jacques, 75014 Paris, France. Tel: +33 144412301; Fax: +33 144412302. Email: veitia{at}cochin.inserm.fr
Received June 17, 2008; Accepted July 15, 2008
The Forkhead transcription factor FOXL2 plays a crucial role in ovarian development and maintenance. In humans, its mutations lead to craniofacial abnormalities, isolated or associated with ovarian dysfunction. Using a combinatorial approach, we identified and characterized a FoxL2 response element (FLRE) and showed that it is highly specific and that it diverges from that of other Forkhead transcription factors. This specificity should prevent aberrant regulation of FOXL2 targets by other members of the family and should prevent ectopic activation of the ovarian differentiation program in testes. We provide evidence that the FLRE is used in naturally occurring promoters. We show that polyAlanine expansions of FOXL2, which are the most frequent pathogenic mutations, induce a length-dependent loss of response on different artificial promoter reporters depending on the number and sequence of the FLREs that they contain. Thus, we provide clear mechanistic evidence explaining how the architecture of promoters influences their sensitivity to decreased transcription factor availability. Furthermore, we speculate that the generally absent ovarian phenotype of patients carrying the most frequent polyAlanine expansion should come from its ability to properly regulate high-affinity ovarian targets. The existence of critical high-affinity ovarian targets would be compatible with the role of FOXL2 in reproduction and ensure developmental and functional robustness. Taken together, our results give mechanistic insights on the molecular pathogenesis of FOXL2 polyAlanine expansions.
The authors wish it to be known that, in their opinion, the first three authors should be regarded as joint First Authors.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Dipietromaria, B. A. Benayoun, A.-L. Todeschini, I. Rivals, C. Bazin, and R. A. Veitia Towards a functional classification of pathogenic FOXL2 mutations using transactivation reporter systems Hum. Mol. Genet., September 1, 2009; 18(17): 3324 - 3333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lamba, J. Fortin, S. Tran, Y. Wang, and D. J. Bernard A Novel Role for the Forkhead Transcription Factor FOXL2 in Activin A-Regulated Follicle-Stimulating Hormone {beta} Subunit Transcription Mol. Endocrinol., July 1, 2009; 23(7): 1001 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Laissue, B Lakhal, B A Benayoun, A Dipietromaria, R Braham, H Elghezal, P Philibert, A Saad, C Sultan, M Fellous, et al. Functional evidence implicating FOXL2 in non-syndromic premature ovarian failure and in the regulation of the transcription factor OSR2 J. Med. Genet., July 1, 2009; 46(7): 455 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Benayoun, F. Batista, J. Auer, A. Dipietromaria, D. L'Hote, E. De Baere, and R. A. Veitia Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: evidence for a regulatory imbalance induced by disease-causing mutations Hum. Mol. Genet., February 15, 2009; 18(4): 632 - 644. [Abstract] [Full Text] [PDF]
|
|